Non-muscle involvement in late-onset Glycogenosis II

Acta Myologica

Volumn 32, Issue 2, 2013, Pages 91-94

  Filosto, Massimiliano ^a   Todeschini, Alice ^a   Cotelli, Maria Sofia ^a   Vielmi, Valentina ^a   Rinaldi, Fabrizio ^a   Rota, Silvia ^a   Scarpelli, Mauro ^b   Padovani, Alessandro ^a  

^a SPEDALI CIVILI   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

Glycogenosis II; GSDII; Pompe disease

Indexed keywords

ARTICLE; BONE DISEASE; CLINICAL FEATURE; FATIGUE; GLYCOGEN STORAGE DISEASE TYPE 2; HEARING IMPAIRMENT; HUMAN; LATE ONSET GLYCOGEN STORAGE DISEASE TYPE 2; MEDICAL HISTORY; NEUROLOGIC DISEASE; PROGNOSIS; SLEEP DISORDERED BREATHING; VASCULAR DISEASE; DISEASE COURSE; GENETICS; GSDII; METABOLISM; ONSET AGE; PATHOPHYSIOLOGY; PHENOTYPE; REVIEW;

ALPHA GLUCOSIDASE; GLYCOGEN;

GLYCOGENOSIS II; GSDII; POMPE DISEASE;

AGE OF ONSET; ALPHA-GLUCOSIDASES; BONE DISEASES; DISEASE PROGRESSION; GLYCOGEN; GLYCOGEN STORAGE DISEASE TYPE II; HUMANS; NERVOUS SYSTEM DISEASES; PHENOTYPE; PROGNOSIS; VASCULAR DISEASES;

EID: 84894447536     PISSN: 11282460     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Toscano A Musumeci O. Pathophysiological mechanisms in Glycogenosis type II. In: Filosto M Toscano A Padovani A eds. Advances in Diagnosis and Management of Glycogenosis II. New York: Nova Science Publisher Inc 2012 pp. 17-21
2. Lamperti C Crugnola V Comi GP et al. Juvenile and adult forms of type II glycogenosis: Clinical aspects In: Filosto M Toscano A Padovani A eds. Advances in Diagnosis and Management of Glycogenosis II. New York: Nova Science Publisher Inc 2012 pp. 39-51
3. Parini R Furlan F Russo P et al. Infantile form of type II Glycogenosis: Clinical aspects. In: Filosto M Toscano A Padovani A eds. Advances in Diagnosis and Management of Glycogenosis II. New York: Nova Science Publisher Inc 2012 pp. 23-37
4. Fuller M Duplock S Turner C et al. Mass spectrometric quantification of glycogen to assess primary substrate accumulation in the Pompe mouse. Anal Biochem 2012; 421:759-63
5. Bijvoet AG Van Hirtum H Vermey M et al. Pathological features of glycogen storage disease type II highlighted in the knockout mouse model. J Pathol 1999;189:416-24
6. DeRuisseau LR Fuller DD Qiu K et al. Neural deficits contribute to respiratory insufficiency in Pompe disease. Proc Natl Acad Sci U S A 2009;106:9419-24
7. Fuller DD Elmallah MK Smith BK et al. The respiratory neuromuscular system in Pompe disease. Respir Physiol Neurobiol 2013; Jun 21 doi: 10.1016/j.resp.2013.06.007 [Epub ahead of print]
8. Martin JJ de Barsy T Van Hoof F et al. Pompe's disease: An inborn lysosomal disorder with storage of glycogen. Acta Neuropathol 1973;23:229-44
9. Mancall EL Aponte GE Berry RG. Pompe's disease (diffuse glycogenosis) with neuronal storage. J Neuropathol Exp Neurol 1965;24:85-96
10. Martini C Ciana G Benettoni A et al. Intractable fever and cortical neuronal glycogen storage in glycogenosis type 2. Neurology 2001;57:906-8
11. Borroni B Cotelli MS Premi E et al. The brain in late-onset glycogenosis II: A structural and functional MRI study. J Inherit Metab Dis 2013;Apr 23 [Epub ahead of print]
12. Chien YH Lee NC Peng SF et al. Brain development in infantileonset Pompe disease treated by enzyme replacement therapy. Pediatr Res 2006;60:349-52
13. Araoz C Sun CN Shenefelt R et al. Glycogenosis type II (Pompe's disease): Ultrastructure of peripheral nerves. Neurology 1974;24:739-42
14. Ebbink BJ Aarsen FK van Gelder CM et al. Cognitive outcome of patients with classic infantile Pompe disease receiving enzyme therapy. Neurology 2012;78:1512-8
15. van der Walt JD Swash M Leake J et al. The pattern of involvement of adult-onset acid maltase deficiency at autopsy. Muscle Nerve 1987;10:272-81
16. Sacconi S Bocquet JD Chanalet S et al. Abnormalities of cerebral arteries are frequent in patients with late-onset Pompe disease. J Neurol 2010;257:1730-3
17. Laforet P Petiot P Nicolino M et al. Dilative arteriopathy and basi lar artery dolichoectasia complicating late-onset Pompe disease. Neurology 2008;70:2063-6
18. Toda G Yoshimuta T Kawano H et al. Glycogen storage disease associated with left ventricular aneurysm in an elderly patient. Jpn Circ J 2001;65:462-4
19. Cotelli M Todeschini A Vielmi V et al. Hemangioma of the semimembranosus muscle in a patient with late-onset Glycogenosis II. Muscle Nerve 2013;47:142-3
20. van den Berg LE Zandbergen AA van Capelle CI et al. Low bone mass in Pompe disease: Muscular strength as a predictor of bone mineral density. Bone 2010;47:643-9
21. Khan A Weinstein Z Hanley DA et al. In vivo bone architecture in Pompe disease using high-resolution peripheral computed tomography. JIMD Rep 2013;7:81-8
22. Prater SN Banugaria SG DeArmey SM et al. The emerging phenotype of long-term survivors with infantile Pompe disease. Genet Med 2012;14:800-10
23. Papadimas GK Terzis G Methenitis S et al. Body composition analysis in late-onset Pompe disease. Mol Genet Metab 2011;102:41-3
24. Oktenli C. Renal magnesium wasting hypomagnesemic hypocalcemia hypocalciuria and osteopenia in a patient with glycogenosis type II. Am J Nephrol 2000;20:412-7
25. Hagemans ML van Schie SP Janssens AC et al. Fatigue: An important feature of late-onset Pompe disease. J Neurol 2007;254:941-5
26. Musumeci O Catalano N Barca E et al. Auditory system involvement in late onset Pompe disease: A study of 20 Italian patients. Mol Genet Metab 2012;107:480-4
27. Vitacca M Vianello A. Pneumological aspects. In: Filosto M Toscano A Padovani A eds. Advances in Diagnosis and Management of Glycogenosis II. New York: Nova Science Publisher Inc 2012 pp. 51-67
28. Mellies U Ragette R Schwake C et al. Sleep-disordered breathing and respiratory failure in acid maltase deficiency. Neurology 2001;57:1290-5
29. Margolis ML Howlett P Goldberg R et al. Obstructive sleep apnea syndrome in acid maltase deficiency. Chest 1994;105:947-9
30. Pascual JM Roe CR. Systemic metabolic abnormalities in adultonset acid maltase deficiency: Beyond muscle glycogen accumulation. JAMA Neurol 2013;70:756-63
31. Begley DJ Pontikis CC Scarpa M. Lysosomal storage diseases and the blood-brain barrier. Curr Pharm Des 2008;14:1566-80.